T2-high asthma phenotypes across lifespan. Issue 3 (29th September 2022)

• Record Type: Journal Article
• Authors: Maison, Nicole; Omony, Jimmy; Illi, Sabina; Thiele, Dominik; Skevaki, Chrysanthi; Dittrich, Anna-Maria; Bahmer, Thomas; Rabe, Klaus Friedrich; Weckmann, Markus; Happle, Christine; Schaub, Bianca; Meyer, Meike; Foth, Svenja; Rietschel, Ernst; Renz, Harald; Hansen, Gesine; Kopp, Matthias Volkmar; von Mutius, Erika; Grychtol, Ruth
• Is Part Of: European respiratory journal. Volume 60:Issue 3(2022)
• Publication Date: 2022-09-29
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.02288-2021
• Languages: English
• ISSNs: 0903-1936

Abstract

Rationale: In adults, personalised asthma treatment targets patients with type 2 (T2)-high and eosinophilic asthma phenotypes. It is unclear whether such classification is achievable in children. Objectives: To define T2-high asthma with easily accessible biomarkers and compare resulting phenotypes across all ages. Methods: In the multicentre clinical All Age Asthma Cohort (ALLIANCE), 1125 participants (n=776 asthmatics, n=349 controls) were recruited and followed for 2 years (1 year in adults). Extensive clinical characterisation (questionnaires, blood differential count, allergy testing, lung function and sputum induction (in adults)) was performed at baseline and follow-ups. Interleukin (IL)-4, IL-5 and IL-13 were measured after stimulation of whole blood with lipopolysaccharide (LPS) or anti-CD3/CD28. Measurements and main results: Based on blood eosinophil counts and allergen-specific serum IgE antibodies, patients were categorised into four mutually exclusive phenotypes: "atopy-only", "eosinophils-only", "T2-high" (eosinophilia + atopy) and "T2-low" (neither eosinophilia nor atopy). The T2-high phenotype was found across all ages, even in very young children in whom it persisted to a large degree even after 2 years of follow-up. T2-high asthma in adults was associated with childhood onset, suggesting early origins of this asthma phenotype. In both children and adults, the T2-high phenotype was characterised by excessive production of specific IgE to allergens (p<0.0001) and, from school age onwards, by increased production of IL-5 after anti-CD3/CD28 stimulation of whole blood. Conclusions: Using easily accessible biomarkers, patients with T2-high asthma can be identified across all ages delineating a distinct phenotype. These patients may benefit from therapy with biologicals even at a younger age. T2-high asthma defined by blood eosinophilia and atopy occurs across all ages and is associated with high levels of allergen-specific IgE, increased propensity for IL-5 production of leukocytes and persistence of asthma into adulthood https://bit.ly/35X11EF